Pipeline Watch: Seven Approvals And 10 Phase III Updates
Executive Summary
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
You may also be interested in...
Pipeline Watch: 18 New Approvals Plus 14 Phase III Trial Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move Renovacor Clover Biopharmaceuticals and More
Recent executive moves in the industry include C-suite changes at Renovacor and Acer Therapeutics. Meanwhile, new directors were appointed at Clover Pharmaceuticals and Chemomab Therapeutics, among others.
Pipeline Watch: Phase III EHA Trial Updates And Nine Approvals
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.